Post-stroke Arm Spasticity Clinical Trial
Official title:
International, Multicenter, Non-interventional, Prospective, Longitudinal Study to Investigate the Effectiveness of Botulinum Toxin A (Dysport®) Injections in Patients Suffering From Post-stroke Arm Spasticity With Respect to Early, Medium or Late Start of Treatment.
Botulinum toxin A (BoNT-A) is effective and safe in alleviating post-stroke spasticity and
reducing the burden of associated symptoms.
The hypothesis for this non-interventional study in arm spasticity (AS-NIS early BIRD) is no
significant difference between naïve and pre-treated patients. The patients will be divided
in sub-groups according to the time interval between occurrence of stroke and start of
treatment (early, medium and late start of treatment according to the first and third
quartiles time distribution). It is hypothesized that the "early" start of treatment group
will have a reduced modified Ashworth scale (MAS) on the elbow and wrist flexors when
compared to the "late" start of treatment group.
n/a